•
Dec 31, 2024

LanzaTech Q4 2024 Earnings Report

LanzaTech reported Q4 2024 results with decreased revenue and increased net loss due to project delays.

Key Takeaways

LanzaTech’s Q4 2024 results reflected revenue challenges tied to delayed biorefining project timelines, while operating costs remained high, resulting in a wider net loss.

Revenue declined to $12.0 million from $20.5 million in Q4 2023 due to timing delays in large biorefining projects.

Net loss widened to $27.0 million from $18.7 million year-over-year.

Gross margin improved to 54% due to a favorable revenue mix including higher CarbonSmart sales.

Cash and investments dropped to $58.1 million from $89.1 million at the end of Q3 2024.

Total Revenue
$12M
Previous year: $20.5M
-41.4%
EPS
-$0.14
Previous year: -$0.09
+55.6%
Revenue decline YoY
-$4.15M
Previous year: $20.5M
-120.2%
Gross Margin
54%
Gross Profit
$6.5M
Previous year: $7M
-7.2%
Cash and Equivalents
$43.5M
Previous year: $121M
-64.0%
Total Assets
$175M
Previous year: $242M
-27.7%

LanzaTech

LanzaTech

LanzaTech Revenue by Segment

Forward Guidance

LanzaTech plans to refocus operations on global deployment but acknowledges ongoing financial challenges.

Positive Outlook

  • Commercial deployment of technology is underway.
  • CarbonSmart revenue nearly doubled YoY in Q4.
  • Continued development on key projects like Project Drake and Norway site.
  • Project SECURE received Department of Energy funding.
  • Potential for additional LanzaJet share issuance from sublicensing events.

Challenges Ahead

  • Significant timing delays on large biorefining projects.
  • Q4 revenue came in at the low end of forecasted range.
  • Net loss increased year-over-year.
  • Operating expenses rose due to project-related costs.
  • Substantial doubt remains regarding ability to continue as a going concern.

Revenue & Expenses

Visualization of income flow from segment revenue to net income